New Clinical Data Highlighting Foundation Medicine’s Next-Generation Sequencing Analysis in Breast Cancer to be Presented at SABCS. Pure Communications, Inc.Dan Budwick, 973-271-6085 ...

CAMBRIDGE, Mass. and BERLIN, May 29, 2019 /PRNewswire/ -- Bayer AG and Foundation Medicine, Inc. today announced a global collaboration for the de ...

One of them, designed for in-solution targeted re-sequencing in collaboration with Chad Nusbaum, Ph.D., co-director of the genome sequencing and analysis program at the Broad Institute, starts ...

Patients with cancer are increasingly having tumor DNA sequenced: The technology has improved, prices have dropped, and such sequencing can identify a new treatment approach. But some ...

A clinical next-generation sequencing test can be designed to target a panel of selected genes, the exome (all known genes, or approximately 1 to 2% of the genome), or the entire genome. Gene ...